Table 4.
Continent/country-wise prevalence of adaptive mutations in the receptor-binding domain of the SARS-CoV-2 Scheme 30 May 2021 till 28 July 2021.
| Continent/ Country |
No. of Studied Sequences | Mutation (%) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R346K | K417N | K417T | N439K | L452Q | L452R | Y453F | S477N | T478K | T478R | E484K | E484Q | F490S | S494P | N501Y | ||
| Africa | 271 | 11.808 | 11.439 | 1.107 | 20.664 | 0.369 | 0.738 | 3.321 | 49.815 | |||||||
| Asia | 1354 | 7.090 | 0.148 | 0.074 | 57.903 | 0.148 | 50.591 | 0.074 | 6.499 | 6.721 | 0.074 | 23.560 | ||||
| Europe § | 7400 | 0.014 | 0.311 | 0.041 | 3.608 | 0.027 | 0.122 | 1.041 | 0.027 | 0.554 | 0.014 | 0.041 | 0.027 | 17.270 | ||
| Germany | 120,429 | 0.033 | 1.476 | 0.453 | 2.148 | 0.121 | 3.310 | 0.002 | 2.352 | 2.819 | 0.011 | 3.582 | 0.134 | 0.542 | 0.174 | 79.022 |
| Switzerland | 17,578 | 0.233 | 0.688 | 0.484 | 2.463 | 0.017 | 2.890 | 9.148 | 2.020 | 0.006 | 1.911 | 0.091 | 0.307 | 0.165 | 58.095 | |
| UK | 229,321 | 0.007 | 0.256 | 0.065 | 0.090 | 0.003 | 49.075 | 0.025 | 48.633 | 0.666 | 0.171 | 0.112 | 0.054 | 48.698 | ||
| North America ‡ | 66 | 3.030 | 1.515 | 6.061 | 1.515 | |||||||||||
| USA | 83,122 | 0.066 | 0.929 | 6.950 | 0.011 | 0.217 | 23.336 | 0.018 | 3.621 | 18.640 | 0.017 | 14.132 | 0.109 | 0.393 | 0.829 | 50.363 |
| Oceania | 634 | 0.946 | ||||||||||||||
| South America | 293 | 37.201 | 0.341 | 1.024 | 62.457 | 1.024 | 0.341 | 39.249 | ||||||||
§ = Europe excluding Germany, Switzerland and the UK; ‡ = North America excluding the USA; empty cell = 4 or more decimal places or 0%. Prevalence of prolonged infections’ mutations from 30 May 2021 till 28 July 2021.